← All organizations
Highest phase reached
Phase 3
First clinical trial
May 31, 2020Last known activity
May 31, 2020
Timeline
2010s
- Jun 1, 2019
Retinagenix Therapeutics— Founded
Drugs by trial phase (1 distinct, 1 trials)
Phase 3 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (1)
- NCT04311112Lead sponsorPhase 2/Phase 3May 31, 2020
Details
- Founded
- Seattle, WA, US Jun 1, 2019
- Last known activity
- May 31, 2020